{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T02:07:55Z","timestamp":1777169275562,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvsvenous.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery: Venous and Lymphatic Disorders"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jvsv.2025.102228","type":"journal-article","created":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T15:38:43Z","timestamp":1742139523000},"page":"102228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Utility of venoactive compounds in post-thrombotic syndrome: A systematic review"],"prefix":"10.1016","volume":"13","author":[{"given":"Monika L.","family":"Gloviczki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julianne","family":"Stoughton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7276-1990","authenticated-orcid":false,"given":"Alessandra","family":"Puggioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Gloviczki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph D.","family":"Raffetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvsv.2025.102228_bib1","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/jamacardio.2022.1988","article-title":"Clinical presentation and Short- and long-term outcomes in patients with isolated distal deep vein thrombosis vs Proximal deep vein thrombosis in the RIETE Registry","volume":"7","author":"Bikdeli","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jvsv.2025.102228_bib2","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jvsv.2014.03.002","article-title":"Validity of international classification of diseases, ninth revision, clinical modification codes for estimating the prevalence of venous ulcer","volume":"2","author":"Gloviczki","year":"2014","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.jvsv.2025.102228_bib3","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ejvs.2005.04.017","article-title":"Venous leg ulcer: a meta-analysis of adjunctive therapy with micronized purified flavonoid fraction","volume":"30","author":"Coleridge-Smith","year":"2005","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvsv.2025.102228_bib4","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.3390\/jcm12185896","article-title":"Epidemiology and diagnosis of post-thrombotic syndrome: qualitative synthesis with a systematic review","volume":"12","author":"Mangwani","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jvsv.2025.102228_bib5","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jvs.2008.10.014","article-title":"Secondary chronic venous disease progresses faster than primary","volume":"49","author":"Labropoulos","year":"2009","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvsv.2025.102228_bib6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1182\/blood.2019002364","article-title":"Long-term treatment of venous thromboembolism","volume":"135","author":"Kearon","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jvsv.2025.102228_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/14779072.2021.1876563","article-title":"Surgical and non-surgical approaches in the management of lower limb post-thrombotic syndrome","volume":"19","author":"Machin","year":"2021","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.jvsv.2025.102228_bib8","first-page":"309","article-title":"Veno-active drugs in the management of chronic venous disease. An international consensus statement: current medical position, prospective views and final resolution","volume":"33","author":"Ramelet","year":"2005","journal-title":"Clin Hemorheol Microcirc"},{"key":"10.1016\/j.jvsv.2025.102228_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.23736\/S0392-9590.18.03999-8","article-title":"Management of chronic venous disorders of the lower limbs. Guidelines according to scientific evidence. Part I","volume":"37","author":"Nicolaides","year":"2018","journal-title":"Int Angiol"},{"key":"10.1016\/j.jvsv.2025.102228_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.23736\/S0392-9590.20.04388-6","article-title":"Management of chronic venous disorders of the lower limbs. Guidelines According to Scientific Evidence. Part II","volume":"39","author":"Nicolaides","year":"2020","journal-title":"Int Angiol"},{"key":"10.1016\/j.jvsv.2025.102228_bib11","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200053RR","article-title":"Diosmin and its glycocalyx restorative and anti-inflammatory effects on injured blood vessels","volume":"36","author":"Mitra","year":"2022","journal-title":"FASEB J"},{"key":"10.1016\/j.jvsv.2025.102228_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/DDDT.S6762","article-title":"Development and use of sulodexide in vascular diseases: implications for treatment","volume":"8","author":"Coccheri","year":"2013","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.jvsv.2025.102228_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/jcm10010029","article-title":"Why venous leg ulcers have difficulty healing: overview on pathophysiology, clinical consequences, and treatment","volume":"10","author":"Raffetto","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jvsv.2025.102228_bib14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/ejvs.2001.1478","article-title":"A placebo-controlled, double-blind study of mesoglycan in the treatment of chronic venous ulcers","volume":"22","author":"Arosio","year":"2001","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvsv.2025.102228_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/jth.14324","article-title":"Sulodexide in venous disease","volume":"17","author":"Carroll","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jvsv.2025.102228_bib16","doi-asserted-by":"crossref","DOI":"10.1201\/9781003328971","volume":"12","author":"Gloviczki","year":"2024","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.jvsv.2025.102228_bib17","article-title":"Rutosides for treatment of post-thrombotic syndrome","volume":"11","author":"Morling","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jvsv.2025.102228_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0268-960X(02)00008-5","article-title":"The post-thrombotic syndrome: current knowledge, controversies, and directions for future research","volume":"16","author":"Kahn","year":"2002","journal-title":"Blood Rev"},{"key":"10.1016\/j.jvsv.2025.102228_bib19","article-title":"Phlebotonics for venous insufficiency","volume":"11","author":"Martinez-Zapata","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jvsv.2025.102228_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"key":"10.1016\/j.jvsv.2025.102228_bib21","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/bmjebm-2022-112102","article-title":"Using Risk of Bias 2 to assess results from randomised controlled trials: guidance from Cochrane","volume":"28","author":"Flemyng","year":"2023","journal-title":"BMJ Evid Based Med"},{"key":"10.1016\/j.jvsv.2025.102228_bib22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.23736\/S0392-9590.20.04356-4","article-title":"Diosmin 600 in adjunction to rivaroxaban reduces the risk of post-thrombotic syndrome after femoropopliteal deep vein thrombosis: results of the RIDILOTT DVT study","volume":"39","author":"Schastlivtsev","year":"2020","journal-title":"Int Angiol"},{"key":"10.1016\/j.jvsv.2025.102228_bib23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s12325-018-0849-z","article-title":"Use of micronized purified flavonoid fraction together with rivaroxaban improves clinical and ultrasound outcomes in femoropopliteal venous thrombosis: results of a pilot clinical trial","volume":"36","author":"Lobastov","year":"2019","journal-title":"Adv Ther"},{"issue":"4 Suppl","key":"10.1016\/j.jvsv.2025.102228_bib24","first-page":"61","article-title":"Double blind study of the pharmacodynamic and clinical activities of 5682 SE in venous insufficiency. Advantages of the new micronized form","volume":"8","author":"Cospite","year":"1989","journal-title":"Int Angiol"},{"key":"10.1016\/j.jvsv.2025.102228_bib25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/026835559400900111","article-title":"A prospective study of the long-term efficacy of two different venoactive drugs in patients with post-thrombotic syndrome","volume":"9","author":"Monreal","year":"1994","journal-title":"Phlebology"},{"key":"10.1016\/j.jvsv.2025.102228_bib26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/026835559400900206","article-title":"Evaluation of a new venoactive micronized flavonoid fraction (S 5682) in symptomatic disturbances of the venolymphatic circulation of the lower limb: a double-blind, placebo-controlled study","volume":"9","author":"Gilly","year":"1994","journal-title":"Phlebology"},{"issue":"4 Suppl","key":"10.1016\/j.jvsv.2025.102228_bib27","first-page":"53","article-title":"Are the phlebotonic properties shown in clinical pharmacology predictive of a therapeutic benefit in chronic venous insufficiency? Our experience with Daflon 500 mg","volume":"8","author":"Tsouderos","year":"1989","journal-title":"Int Angiol"},{"key":"10.1016\/j.jvsv.2025.102228_bib28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/026835559901400405","article-title":"The beneficial augmentative effect of micronised purified flavonoid fraction (MPFF)on the healing of leg ulcers: an open, multicentre, controlled, randomised study","volume":"14","author":"Glinski","year":"1999","journal-title":"Phlebology"},{"issue":"Suppl 1","key":"10.1016\/j.jvsv.2025.102228_bib29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000179263","article-title":"Benefit of a 2-month treatment with a micronized, purified flavonoidic fraction on venous ulcer healing. A randomized, double-blind, controlled versus placebo trial","volume":"17","author":"Guilhou","year":"1997","journal-title":"Int J Microcirc Clin Exp"},{"key":"10.1016\/j.jvsv.2025.102228_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/000331979704800113","article-title":"Efficacy of Daflon 500 mg in venous leg ulcer healing: a double-blind, randomized, controlled versus placebo trial in 107 patients","volume":"48","author":"Guilhou","year":"1997","journal-title":"Angiology"},{"key":"10.1016\/j.jvsv.2025.102228_bib31","first-page":"24","article-title":"Efficacy of a 6-month treatment with Daflon 500 mg in patients with venous leg ulcers associated with chronic venous insufficiency","volume":"22","author":"Roztocil","year":"2003","journal-title":"Int Angiol"},{"key":"10.1016\/j.jvsv.2025.102228_bib32","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1055\/s-0037-1613116","article-title":"Randomised, double blind, multicentre, placebo controlled study of sulodexide in the treatment of venous leg ulcers","volume":"87","author":"Coccheri","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jvsv.2025.102228_bib33","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1177\/000331979905001102","article-title":"Treatment of venous leg ulcers with sulodexide","volume":"50","author":"Scondotto","year":"1999","journal-title":"Angiology"},{"key":"10.1016\/j.jvsv.2025.102228_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/iwj.14833","article-title":"Investigating low rates of compliance to graduated compression therapy for chronic venous insufficiency: a systematic review","volume":"21","author":"Stevenson","year":"2024","journal-title":"Int Wound J"},{"key":"10.1016\/j.jvsv.2025.102228_bib35","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ejvs.2017.11.025","article-title":"A Summation analysis of compliance and complications of compression Hosiery for patients with chronic venous disease or post-thrombotic syndrome","volume":"55","author":"Kankam","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvsv.2025.102228_bib36","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1007\/s12325-023-02643-6","article-title":"VEIN STEP: a prospective, observational, international study to assess effectiveness of conservative treatments in chronic venous disease","volume":"40","author":"Mezalek","year":"2023","journal-title":"Adv Ther"},{"key":"10.1016\/j.jvsv.2025.102228_bib37","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2165\/00128071-200304080-00007","article-title":"The social and economic burden of venous leg ulcers: focus on the role of micronized purified flavonoid fraction adjuvant therapy","volume":"4","author":"Simka","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jvsv.2025.102228_bib38","first-page":"478","article-title":"Investigation of the efficacy of oxerutins compared to placebo in patients with chronic venous insufficiency treated with compression stockings","volume":"46","author":"Unkauf","year":"1996","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.jvsv.2025.102228_bib39","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(96)90467-5","article-title":"Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency","volume":"347","author":"Diehm","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jvsv.2025.102228_bib40","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1177\/1076029614533143","article-title":"The efficacy of sulodexide in the prevention of postthrombotic syndrome","volume":"20","author":"Luzzi","year":"2014","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jvsv.2025.102228_bib41","first-page":"238","article-title":"Prevention of recurrent venous thrombosis and post-thrombotic syndrome","volume":"66","author":"Belcaro","year":"2018","journal-title":"Minerva Cardioangiol"},{"key":"10.1016\/j.jvsv.2025.102228_bib42","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1177\/0003319706291392","article-title":"Rapid relief of signs\/symptoms in chronic venous microangiopathy with pycnogenol: a prospective, controlled study","volume":"57","author":"Cesarone","year":"2006","journal-title":"Angiology"},{"key":"10.1016\/j.jvsv.2025.102228_bib43","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1007\/s12325-023-02657-0","article-title":"Cardiovascular insights for the appropriate management of chronic venous disease: a narrative review of implications for the use of venoactive drugs","volume":"40","author":"Gianesini","year":"2023","journal-title":"Adv Ther"},{"key":"10.1016\/j.jvsv.2025.102228_bib44","doi-asserted-by":"crossref","first-page":"91350","DOI":"10.18632\/oncotarget.20518","article-title":"Sulodexide recovers endothelial function through reconstructing glycocalyx in the balloon-injury rat carotid artery model","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jvsv.2025.102228_bib45","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-049557","article-title":"MUFFIN-PTS trial, micronized purified flavonoid fraction for the treatment of post-thrombotic syndrome: protocol of a randomised controlled trial","volume":"11","author":"Galanaud","year":"2021","journal-title":"BMJ Open"}],"container-title":["Journal of Vascular Surgery: Venous and Lymphatic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213333X25000630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213333X25000630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T10:41:22Z","timestamp":1749811282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213333X25000630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2213333X25000630"],"URL":"https:\/\/doi.org\/10.1016\/j.jvsv.2025.102228","relation":{},"ISSN":["2213-333X"],"issn-type":[{"value":"2213-333X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of venoactive compounds in post-thrombotic syndrome: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery: Venous and Lymphatic Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvsv.2025.102228","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.","name":"copyright","label":"Copyright"}],"article-number":"102228"}}